CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020

NEXT STORY
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS
PREV STORY
AnaptysBio Announces Orphan Drug Designation of Imsidolimab For Treatment of Generalized Pustular Psoriasis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Announces U.S. Food and Drug Administration (FDA) Approval of EMPAVELI™ (pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

author_avatar
NASDAQ Market News

Neovacs issued new broad patent in China for IFNalpha Kinoid

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE  NEOVACS ISSUED NEW BROAD PATENT IN ...

author_avatar
NASDAQ Market News

Valneva Announces Publication of 2020 Universal Registration Document and Provides Business Updates

author_avatar
NASDAQ Market News